PCLOF (PharmaCielo) Other Current Receivables: $0.27 Mil (As of Dec. 2025)


What is PharmaCielo Other Current Receivables?

PharmaCielo PCLOF +27.76% Other Current Receivables is $0.27 Mil as of Dec. 2025. The stock has 5 warning signs investors should review.

PharmaCielo's Other Current Receivables for the quarter that ended in Dec. 2025 was $0.27 Mil.

PharmaCielo's quarterly Other Current Receivables increased from Jun. 2025 ($0.22 Mil) to Sep. 2025 ($0.24 Mil) and increased from Sep. 2025 ($0.24 Mil) to Dec. 2025 ($0.27 Mil).

PharmaCielo's annual Other Current Receivables increased from Dec. 2021 ($0.23 Mil) to Dec. 2022 ($0.59 Mil) but then declined from Dec. 2022 ($0.59 Mil) to Dec. 2023 ($0.40 Mil).

PharmaCielo Other Current Receivables Related Terms

PharmaCielo Other Current Receivables Historical Data

* Premium members only.

The historical data trend for PharmaCielo's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaCielo Other Current Receivables Chart

PharmaCielo Annual Data
Trend Aug17 Aug18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Receivables
Get a 7-Day Free Trial 0.85 0.45 0.23 0.59 0.40

PharmaCielo Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Jun25 Sep25 Dec25
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.43 0.18 0.22 0.24 0.27

PharmaCielo Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of $0.27 Mil mean?
PharmaCielo (PCLOF) has a Other Current Receivables of $0.27 Mil as of Dec. 2025. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on PharmaCielo and its competitors.
Is PharmaCielo's Other Current Receivables too high?
PharmaCielo's current Other Current Receivables is $0.27 Mil.
How does PharmaCielo's Other Current Receivables compare to ZTS and UTHR?
PharmaCielo's Other Current Receivables of $0.27 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Drug Manufacturers company?
A good Other Current Receivables depends on the Drug Manufacturers industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on PharmaCielo and its competitors. PharmaCielo's current Other Current Receivables is $0.27 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaCielo stock overvalued right now?
Based on GuruFocus' analysis, PharmaCielo (PCLOF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.11, compared to a current price of $0.06 — trading 44.3% below its estimated fair value. The current Other Current Receivables is $0.27 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For PharmaCielo (PCLOF), the current Other Current Receivables is $0.27 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PharmaCielo Business Description

Other Exchanges PCLO:Canada
Address 82 Richmond Street East, Suite 805, Toronto, ON, CAN, M5C 1P1
PharmaCielo Ltd is a pharma company, with a focus on ethical and sustainable processing and supplying of both THC(tetrahydrocannabinol) and CBD (cannabidiol) medicinal cannabis extracts. It is licensed to produce both CBD-dominant and THC-dominant cannabis extracts. The company operates in Canada, Colombia, Italy, and Mexico and generates the majority of its revenue in the form of the Sale of Cannabis derivative products in America followed by Australia, Africa and Europe.